Faknostics
UEI: TK5AKDP8CSZ7
• CAGE: 85VE1
Overview
Awardee Type
Parent
Federal Capability Statement
A comprehensive cancer diagnostics and therapeutics company based on a critical protein for cancer development and survival, Focal Adhesion Kinase (FAK).
Keywords
Cancer diagnostics, cancer drug discovery, focal adhesion kinase (FAK) inhibitors, focal adhesion kinase, fibrosis, cancer, cirrhosis
Website
Headquarters
Phoenix, AZ
United States
United States
Most Recent Award
Sept. 15, 2024
Calculating
Federal grant recipient
FAKNOSTICS LLC
(UEI TK5AKDP8CSZ7, CAGE 85VE1)
is headquartered in Phoenix AZ.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The partnership
was founded in May 2014 and
federally registered in
September 2018.
Federal Award Analysis
Faknostics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
FAKNOSTICS LLC
Division Name
FAKNOSTICS, LLC
Division Number
FAKNOSTICS
UEI
TK5AKDP8CSZ7
CAGE Code
85VE1
SBA Certifications
None
Self Certifications
Woman Owned Business
Woman Owned Small Business
Woman Owned Small Business
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 30, 2014
Initial Registration
Sept. 5, 2018
Last Registration
Nov. 5, 2024
Registration Activation
Nov. 5, 2024
Registration Expiration
Oct. 31, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
NY
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No